James Ballard, MD
Interventional Cardiology · Madison, WINPI 1508209354
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 71.9% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $4,217, 7.9 times the $535 reported in 2019.
Across 49 payments — averaging $167.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$6K
- Medtronic$2K
- Abbott$294
- Zimmer Biomet$269
- Cardinal Health 200 LLC$92
- Boston Scientific$55
- plus $70 from 3 others
What the payments were for
- Consulting fees$4,08550%
- Grants$270%
- Travel & lodging$2,13026%
- Food & beverage$1,91423%
- Education$421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 16 | $5,891 |
| Medtronic(2 entities) | 15 | $1,527 |
| Abbott | 8 | $294 |
| Zimmer Biomet | 2 | $269 |
| Cardinal Health 200 LLC | 2 | $92 |
| Boston Scientific | 2 | $55 |
| Cook Medical LLC | 2 | $27 |
| Novo Nordisk | 1 | $25 |
| Abiomed | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,198 in reported general payments places this provider in the 65th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $98,642 |
| JardianceEmpagliflozin | 47 | $43,548 |
| EntrestoSacubitril/Valsartan | 15 | $20,221 |
| Metoprolol Succinate | 271 | $4,508 |
| Rosuvastatin Calcium | 117 | $1,950 |
| ClopidogrelClopidogrel Bisulfate | 117 | $1,581 |
| Atorvastatin Calcium | 142 | $1,369 |
| Losartan Potassium | 142 | $1,269 |
| Carvedilol | 147 | $1,246 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 80 | $1,133 |
| Bumetanide | 13 | $1,012 |
| Flecainide Acetate | 13 | $789 |
| Metoprolol Tartrate | 66 | $684 |
| Diltiazem 24hr ErDiltiazem Hcl | 16 | $652 |
| Furosemide | 102 | $644 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Madison
- Kurt JacobsonMadison$24K
- Amish RavalMadison$21K
- Alexandra ErdmannMadison$7K
- Benjamin CiskeMadison$5K
- Giorgio GimelliMadison$5K
- Michael SalingerMilwaukee$216K
- Arun KalyanasundaramMarshfield$201K
- Michael RosenbergManitowoc$111K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.